Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$10.88 - $20.05 $249,576 - $459,926
22,939 Added 96.57%
46,692 $532,000
Q4 2022

Feb 13, 2023

SELL
$10.88 - $20.05 $116,339 - $214,394
-10,693 Reduced 31.04%
23,753 $271,000
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $65,942 - $108,357
4,106 Added 13.53%
34,446 $586,000
Q2 2022

Aug 05, 2022

BUY
$20.49 - $39.72 $166,050 - $321,890
8,104 Added 36.45%
30,340 $652,000
Q1 2022

May 09, 2022

BUY
$28.19 - $46.6 $403,286 - $666,659
14,306 Added 180.4%
22,236 $822,000
Q4 2021

Feb 07, 2022

BUY
$41.2 - $73.6 $130,068 - $232,355
3,157 Added 66.14%
7,930 $361,000
Q3 2021

Oct 28, 2021

SELL
$59.15 - $91.99 $53,826 - $83,710
-910 Reduced 16.01%
4,773 $302,000
Q1 2021

May 06, 2021

SELL
$57.62 - $95.6 $195,043 - $323,606
-3,385 Reduced 37.33%
5,683 $387,000
Q4 2020

Feb 12, 2021

SELL
$41.43 - $77.09 $191,240 - $355,847
-4,616 Reduced 33.73%
9,068 $657,000
Q3 2020

Nov 06, 2020

BUY
$30.88 - $37.94 $98,198 - $120,649
3,180 Added 30.27%
13,684 $520,000
Q2 2020

Jul 29, 2020

SELL
$18.95 - $35.43 $14,060 - $26,289
-742 Reduced 6.6%
10,504 $373,000
Q1 2020

May 14, 2020

BUY
$13.94 - $28.25 $156,769 - $317,699
11,246 New
11,246 $245,000
Q3 2019

Nov 12, 2019

SELL
$20.03 - $40.08 $113,950 - $228,015
-5,689 Closed
0 $0
Q2 2019

Aug 12, 2019

SELL
$25.78 - $39.77 $43,284 - $66,773
-1,679 Reduced 22.79%
5,689 $205,000
Q1 2019

May 15, 2019

BUY
$22.09 - $39.21 $162,759 - $288,899
7,368 New
7,368 $232,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.